Virtual Training Role-Plays to Improve Patient Suicide Outcomes in Primary Care Settings

摘要 SIMmersion，与家庭健康研究所（IFH）和教育发展中心合作 (EDC)提议开发一个网上培训产品， 自杀预防角色扮演互动培训 （SPiRIT），一系列4个模块，用于培训提供者更有效地管理筛查阳性的患者， 自杀的风险在这个阶段I/阶段II快速通道应用。如果获得资助，该团队将开发风险 评估模块在第一阶段，并利用组内的前，后设计，以评估其可行性。二十 将招聘执业临床医生使用该模块并完成一项事前事后知识测试。在第二阶段， 该团队将开发S 将使用历史对照试验测试产品对患者结局产生积极影响的有效性。 试验（HCT）招募了5个IFH研究中心的65名执业临床医生。 计划，获得致命手段，并愿意接受转介模块。 所有提供者都将接受培训并保持耐心 培训后将跟踪6个月的成果。该数据集将与6个月的历史数据进行比较。 同一提供商组的数据。本研究的主要结果将衡量参与者获得 与以下方面相关的患者结局改善：1）当天C-SSRS筛查率; 2）增加自杀率 问题列表; 3）当天安全计划的比率; 4）当天C-SSRS生命线/最近的比率 完成率; 5）当天风险评估率; 6）院内接受率和出勤率 干预后患者在第一次就诊时被转诊; 7） 有自杀企图的记录最终，该产品的开发和成功测试将提供 美国卫生保健系统是一种新技术，可以提高临床医生的信心和技能， 有自杀风险的病人。此外，如果有效，该产品将对 患者结果，这是任何试图培训医疗保健专业人员的培训产品的重要组成部分。 拟议产品的实用性和可扩展性将使医疗保健系统朝着零死亡的目标迈进 与“零自杀”方法一致

ABSTRACT SIMmersion, in collaboration with the Institute for Family Health (IFH) and the Educational Development Center (EDC) propose to develop a web-based training product, Suicide Prevention Role-plays for Interactive Training (SPiRIT), a series of 4 modules to train providers to more effectively manage patients who screen positive for risk of suicide in this Phase I/Phase II fast-track application. If funded, the team will develop the Risk Assessment module in Phase I and utilize a within group pre-post design to evaluate its feasibility. Twenty practicing clinicians will be recruited to utilize the module and complete a pre-post knowledge test. In Phase II, the team will develop S The efficacy of the product to positively influence patient outcomes will be tested with a Historically Controlled Trial (HCT) enlisting 65 practicing clinicians across five IFH sites. afety Planning, Access to Lethal Means, and Willingness to Accept a Referral modules. All providers will be trained and patient outcomes will be tracked for 6 months post training. This data set will be compared to 6 months of historical data for the same provider group. Primary outcomes of this study will measure the participants' ability in obtain improved patient outcomes related to: 1) rate of same-day C-SSRS Screening; 2) rate of suicide being added to the problem list; 3) rate of same-day safety planning; 4) rate of same day C-SSRS Lifeline/Recent Completion; 5) rate of same-day Risk Assessment; 6) rate of acceptance and attendance to within-Institute referrals for post intervention patients who are offered the referral at the first visit; 7) and lower rates of documented suicide attempts. Ultimately, the development and successful testing of this product would provide the US health care system a novel technology to scale up a clinician's confidence and skill to better manage patients who identify as at-risk for suicide. Additionally, if effective, this product will have a direct impact on patient outcomes, a vital component to any training product that attempts to train health care professionals. The utility and scalability of the proposed product will move health care systems toward the goal of zero deaths from suicide consistent with the Zero suicide approach.